EUVIMEDEUVIMED entdecken
Open Access

Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression

Xiaohong Xia, Tumei Hu, Xiaoyue He, Yuan Liu, Cuifu Yu, Weiyao Kong, Yuning Liao, Daolin Tang, Jinbao Liu, Hongbiao Huang

International Journal of Biological Sciences · 2023

DOI: 10.7150/ijbs.75852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2023. Verfasst von Xiaohong Xia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Proteolysis, Erb-b2 Receptor Tyrosine Kinases, Ubiquitination. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HER2 is a transmembrane receptor with intrinsic tyrosine kinase activity that is overexpressed in almost 25% of human breast cancers. Here, we report that the neddylation of HER2 is a new post-translational modification that controls its expression and oncogenic activity in human breast cancer. Two critical members in the neddylation pathway, NEDD8 and NEDD8-activating enzyme E1 subunit 1 (NAE1), are detected in human breast specimens. Overexpressed NEDD8 and NAE1 are positively correlated with HER2 expression in human breast cancer. Subsequent structure and function experiments show that HER2 directly interacts with NEDD8 and NAE1, whereas HER2 protein expression is decreased by neddylation depletion. Mechanistically, neddylation inhibition promotes the degradation of HER2 protein by improving its ubiquitination. HER2 overexpression abrogates neddylation depletion-triggered cell growth suppression. The inhibition of neddylation synergized with trastuzumab significantly suppresses growth of HER2 positive breast cancer. Collectively, this study demonstrates a previously undiscovered role of NEDD8-dependent HER2 neddylation promotes tumor growth in breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsProteolysisErb-b2 Receptor Tyrosine KinasesUbiquitinationNEDD8 ProteinFemaleHumansProtein Processing, Post-TranslationalDisease ProgressionUbiquitin-Activating Enzymes

Stichwörter der Autor:innen

HER2breast cancerdegradationneddylationubiquitin

Substanzen

Erb-b2 Receptor Tyrosine KinasesNEDD8 ProteinERBB2 protein, humanNAE protein, humanUbiquitin-Activating Enzymes

Autor:innen und Institutionen

  • Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Department of Surgery, UT Southwestern Medical Center, Dallas, Texas 75390, USA.

Zitieren

APA

Xia, X., Hu, T., He, X., Liu, Y., Yu, C., Kong, W., Liao, Y., Tang, D., Liu, J., & Huang, H. (2023). Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.75852

Vancouver

Xia X, Hu T, He X, Liu Y, Yu C, Kong W, et al. Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression. International Journal of Biological Sciences. 2023. doi:10.7150/ijbs.75852

BibTeX
@article{Xia2023,
  author = {Xia, Xiaohong and Hu, Tumei and He, Xiaoyue and Liu, Yuan and Yu, Cuifu and Kong, Weiyao and Liao, Yuning and Tang, Daolin and Liu, Jinbao and Huang, Hongbiao},
  title = {Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression},
  journal = {International Journal of Biological Sciences},
  year = {2023},
  doi = {10.7150/ijbs.75852}
}
Kostenlos starten →